Michael Gartside

Michael Gartside

UNVERIFIED PROFILE

Are you Michael Gartside?   Register this Author

Register author
Michael Gartside

Michael Gartside

Publications by authors named "Michael Gartside"

Are you Michael Gartside?   Register this Author

22Publications

826Reads

23Profile Views

Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer.

Mol Oncol 2019 04 18;13(4):738-756. Epub 2019 Jan 18.

School of Biomedical Science, Institute of Health & Biomedical Innovation, Queensland University of Technology located within the Translational Research Institute, Brisbane, Australia.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/1878-0261.12
Publisher Site
http://dx.doi.org/10.1002/1878-0261.12422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441928PMC
April 2019

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

J Natl Cancer Inst 2015 Feb 13;107(2). Epub 2014 Dec 13.

Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH); Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA); Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG); Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB); Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB); Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO); Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ); Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG); Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ); Translational Genomics Institute, Phoenix, AZ (JMT); University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM); Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334787PMC
February 2015

FGFR2 mutations are rare across histologic subtypes of ovarian cancer.

Gynecol Oncol 2010 Apr 27;117(1):125-9. Epub 2010 Jan 27.

Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.12.002DOI Listing
April 2010

Targeting and conditional inactivation of the murine Men1 locus using the Cre recombinase: loxP system.

Genesis 2002 Feb;32(2):150-1

Joint Experimental Oncology Program, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gene.10061DOI Listing
February 2002